New hope for stroke recovery: trial tests Two-Drug combo
NCT ID NCT07483281
Summary
This study is testing whether adding a drug called human urinary kallidinogenase to the standard stroke treatment (reteplase) helps patients recover better. It will involve 220 adults who have just had an ischemic stroke and can receive treatment within 4.5 hours. The main goal is to see if the combination leads to less disability 90 days after the stroke, without increasing the risk of dangerous bleeding.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
China-Japan Union Hospital of Jilin University
Changchun, Jilin, 130033, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.